UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025172
Receipt number R000028615
Scientific Title Research to verify the effects of KT index in swallowing function improvement of the older patients with pneumonia
Date of disclosure of the study information 2016/12/07
Last modified on 2020/01/30 05:30:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research to verify the effects of KT index in swallowing function improvement of the older patients with pneumonia

Acronym

Research to verify the effects of KT index

Scientific Title

Research to verify the effects of KT index in swallowing function improvement of the older patients with pneumonia

Scientific Title:Acronym

Research to verify the effects of KT index

Region

Japan


Condition

Condition

Older patients (65 years and over) with pneumonia

Classification by specialty

Medicine in general Pneumology Rehabilitation medicine
Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify whether comprehensive intervention with KT index improve the swallowing function of the older patients with pneumonia or not.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Functional Oral intake Scale of the older patients with pneumonia at discharge or one month after admission

Key secondary outcomes

Nutritional intake on admission intake (including both parenteral and enteral artificial nutrition), ADL (Barthel Index each item and the total score), hospital discharge rate (15 days, 30 days after admission), period of Nil per Os after admission, discharge upon oral ingestion the presence or absence of resuming oral intake at discharge, period of antibiotic administration, home discharge rate, mortality


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

・Multidisciplinary comprehensive evaluation and intervention
・Recording on the time-series evaluation sheet: index comprised 13 items. each item is rated from 1 (worst) to 5 (best) points.
・Once a week or more of multidisciplinary meeting with the time-series evaluation sheet.
・Professional assessment and treatment for the items with lower evaluation point.
・The maintenance and strengthening for the items with higher evaluation point.
・Medical intervention, such as medication or oxygen administration to improve overall condition.
・Dysphagia rehabilitation to improve swallowing function.
・Intervention for keep position and endurance while eating and improve daily activities.
・Confirmation of dietary intake level and food texture for adequate nutritional status.

Interventions/Control_2

・Once a week or more of multidisciplinary meeting for adequate evaluation and intervention.
・Standard treatment for the patients with pneumonia

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

・The patients with pneumonia admitted to the hospital
・The patients with written informed consent.

Key exclusion criteria

・The case who does not have oral intake before admission.
・The case with mild pneumonia (A-DROP Score 0), or the case who is not hospitalized.
・The case who does not agree to the study participants
・The case who has not been consulted to the team

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Shamoto

Organization

Fukushima Medical University
Minamisoma Municipal General Hospital

Division name

Department of Disaster and Comprehensive medicine, Department of Neurosurgery

Zip code

960-1247

Address

2-54-6 Takami-chou, Haramachi ward, Minamisoma City, Fukushima, Japan 975-0033

TEL

0244-22-3181

Email

hshamoto@rc4.so-net.ne.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Shamoto

Organization

Fukushima Medical University, Minamisoma Municipal General Hospital

Division name

Department of Disaster and Comprehensive medicine, Department of Neurosurgery

Zip code

960-1247

Address

2-54-6 Takami-chou, Haramachi ward, Minamisoma City, Fukushima, Japan 975-0033

TEL

0244-22-3181

Homepage URL


Email

hshamoto@rc4.so-net.ne.jp


Sponsor or person

Institute

Non-profit organization Kuchi-kara Taberu Shiawase-wo Mamoru-kai, Kanagawa, Japan

Institute

Department

Personal name



Funding Source

Organization

Non-profit organization Kuchi-kara Taberu Shiawase-wo Mamoru-kai, Kanagawa, Japan

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Minamisoma Municipal General Hospital

Address

2-54-6 Takami-chou, Haramachi ward, Minamisoma City, Fukushima, Japan 975-0033

Tel

0244-22-3181

Email

sato.ryo@city.minamisoma.lg.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

玉名郡市医師会立 玉名地域保健医療センター(熊本県)、南相馬市立総合病院(福島県)
Tamana Regional Health Medical Center, Minamisoma Municipal General Hospital


Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 07 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-bin/ctr/ctr_view_reg.cgi?recptno=R000028615

Publication of results

Published


Result

URL related to results and publications

https://upload.umin.ac.jp/cgi-bin/ctr/ctr_view_reg.cgi?recptno=R000028615

Number of participants that the trial has enrolled

112

Results

The median FOIS level and the number of patients with oral intake at discharge were 4 (IQR 4-6) and 89, respectively. The duration of nil per os was 2 (IQR 1-5) days. Clusters were not matched in the presence of KT-certified medical stuff. The median FOIS levels of 53 patients in the intervention group and 59 patients in the control group were 5 (IQR 4-6) and 4 (IQR 4-5), respectively, showing no statistically significant differences (P=0.76).

Results date posted

2020 Year 01 Month 20 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients 65 years and older admitted to the hospitals with pneumonia were enrolled in the study. One hundred and twelve patients who participated from 10 hospitals, with a median age of 88 years (IQR 80-91), were examined.

Participant flow

Patients without ordinary food intake at admission, with mild pneumonia (A-DROP Score 0, described later), who did not agree to participate in the trial, and who had not been referred to the multidisciplinary comprehensive care (MDCC) team were excluded.

Adverse events

None

Outcome measures

Primary Outcomes
The Functional Oral Intake Scale (FOIS) at discharge or 1 month after admission
Secondary Outcomes
Duration of hospitalization, duration of nil per os after admission, resumption of oral intake at discharge, nutritional intake (kcal) at discharge or 1 month after admission, and period of antibiotic administration

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 07 Day

Date of IRB

2016 Year 10 Month 13 Day

Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date

2018 Year 01 Month 31 Day

Date of closure to data entry

2018 Year 02 Month 28 Day

Date trial data considered complete

2018 Year 04 Month 30 Day

Date analysis concluded

2018 Year 05 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 12 Month 07 Day

Last modified on

2020 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028615


Research Plan
Registered date File name
2019/02/26 KTBCランダム化試験(詳細).pdf

Research case data specifications
Registered date File name
2019/05/15 data set.pdf

Research case data
Registered date File name
2019/05/15 data for analysis.pdf